Thus, CSF GAP-43 increases in AD may mirror Aβ-induced hyperexcitatory synaptic changes39, yet this remains to be specifically tested in future studies combining electrophysiological measures of neuronal activity with soluble GAP-43 measures in AD patients and/or AD model systems. The gene discussed is GAP43; the disease is Alzheimer disease.